Raphas Co., Ltd. (KOSDAQ:214260)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacturing and Sales of Biodegradable Microneedles			27.94B	23.64B	20.34B	17.86B	18.17B
Manufacturing and Sales of Biodegradable Microneedles Growth			18.18%	16.22%	13.87%	-1.69%	80.75%
Total			27.94B	23.64B	20.34B	17.86B	18.17B
Total Growth			18.18%	16.22%	13.87%	-1.69%	80.75%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States of America			2.80B	3.44B	4.06B	4.29B	5.09B
United States of America Growth			-18.49%	-15.25%	-5.34%	-15.79%	461.94%
Republic of Korea			18.92B	15.28B	7.55B	5.62B	5.95B
Republic of Korea Growth			23.88%	102.26%	34.29%	-5.46%	23.54%
Other			647.77M	1.27B	2.42B	1.45B	1.63B
Other Growth			-48.94%	-47.66%	67.64%	-11.06%	-33.79%
Japan			5.56B	3.66B	6.31B	6.51B	5.50B
Japan Growth			52.12%	-42.03%	-3.07%	18.19%	193.56%
Total			27.94B	23.64B	20.34B	17.86B	18.17B
Total Growth			18.18%	16.22%	13.87%	-1.69%	80.75%

Source: S&P Global Market Intelligence.